Risks and benefits of urinary catheterisation during inpatient diuretic therapy for acute heart failure: a

Gregor John1,2,3, Marc Arcens3, Gregory Berra3

  • 1Department of Medicine, Université de Genève, Geneva, Switzerland gregor.john@rhne.ch.

BMJ Open
|May 2, 2023
PubMed

Insights

Urinary catheterisation (UC) in acute congestive heart failure patients did not improve weight loss during diuretic therapy. UC increased urinary tract infection (UTI) risk without offering clinical benefits, suggesting it should not be systematically used.

Area of Science:

  • Cardiology
  • Nephrology
  • Infectious Diseases

Background:

  • Patients with acute congestive heart failure (HF) often receive urinary catheterisation (UC) upon hospital admission.
  • The clinical utility and potential risks of UC in this population remain subjects of investigation.

Purpose of the Study:

  • To evaluate the clinical benefits of UC regarding weight loss in acute congestive HF patients undergoing diuretic therapy.
  • To assess the impact of UC on the risk of urinary tract infection (UTI) and other clinical outcomes.

Main Methods:

  • A retrospective, non-inferiority study compared 113 catheterised HF patients with 346 non-catheterised patients within 24 hours of diuretic therapy.
  • Primary endpoint: weight loss at 48 hours. Secondary endpoints: time to target weight, diuretic discontinuation, respiratory failure resolution, UTI, readmission, and mortality.

Main Results:

  • Weight loss at 48 hours was not statistically different between groups (adjusted difference: 0.43 kg, favoring UC, p<0.01 for non-inferiority).
  • UC did not significantly impact time to target weight, diuretic discontinuation, or respiratory failure resolution.
  • UC significantly increased UTI risk (aHR 2.5) but showed no association with readmission or 1-year mortality.

Conclusions:

  • Urinary catheterisation within 24 hours of initiating diuretic treatment for acute congestive HF offers no significant clinical benefit in terms of weight loss or clinical improvement.
  • UC is associated with an increased risk of urinary tract infections.
  • The findings argue against the routine, systematic use of urinary catheterisation in patients with acute congestive heart failure receiving diuretic therapy.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
86
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
81
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
433
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
42
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
17
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
30